233MO Ovarian function suppression in HR-positive, HER2-positive breast cancer: An exploratory analysis from the HERA trial

Autor: Moon, S., Bae, S.J., Kook, Y., Ho, B. Seung, Minji, L., Ahn, S.G., Jeong, J.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S310-S310
Databáze: ScienceDirect